The DOI matches its OpenAlex record; 39 of the 39 references it cites were found in a registry or an index.
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Abstract
Transcription of genes encoding cytochrome P450 3A (CYP3A) monooxygenases is induced by a variety of xenobiotics and natural steroids. There are marked differences in the compounds that induce CYP3A gene expression between species. Recently, the mouse and human pregnane X receptor (PXR) were shown to be activated by compounds that induce CYP3A expression. However, most studies of CYP3A regulation have been performed using rabbit and rat hepatocytes. Here, we report the cloning and characterization of PXR from these two species. PXR is remarkably divergent between species, with the rabbit, rat, and human receptors sharing only approximately 80% amino acid identity in their ligand-binding domains. This sequence divergence is reflected by marked pharmacological differences in PXR activation profiles. For example, the macrolide antibiotic rifampicin, the antidiabetic drug troglitazone, and the hypocholesterolemic drug SR12813 are efficacious activators of the human and rabbit PXR but have little activity on the rat and mouse PXR. Conversely, pregnane 16alpha-carbonitrile is a more potent activator of the rat and mouse PXR than the human and rabbit receptor. The activities of xenobiotics in PXR activation assays correlate well with their ability to induce CYP3A expression in primary hepatocytes. Through the use of a novel scintillation proximity binding assay, we demonstrate that many of the compounds that induce CYP3A expression bind directly to human PXR. These data establish PXR as a promiscuous xenobiotic receptor that has diverged during evolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Self-citationThe RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Arky, R. A. (1994) · Cited by 2,632
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Self-citationLigand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,958
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
Self-citationAn Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Self-citationMolecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169
Self-citationSXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., & Berkenstam, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 872
Honkakoski, P., Zelko, I., Sueyoshi, T., & Negishi, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5652 · Cited by 700
Willson, T. M., Cobb, J. E., Cowan, D. J., Wiethe, R. W., Correa, I. D., Prakash, S. R., Beck, K. D., Moore, L. B., Kliewer, S. A., & Lehmann, J. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950395a · Cited by 638
Self-citationSensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
Mukherjee, R., Davies, P. J. A., Crombie, D. L., Bischoff, E. D., Cesario, R. M., Jow, L., Hamann, L. G., Boehm, M. F., Mondon, C. E., Nadzan, A. M., et al. (1997) · Nature · doi:10.1038/386407a0 · Cited by 605
Update: Clinically Significant Cytochrome P‐450 Drug Interactions
Michalets, E. L. (1998) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03830.x · Cited by 597
Hepatic Dysfunction Associated with Troglitazone
Watkins, P. B., & Whitcomb, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381314 · Cited by 446
Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids
Boehm, M. F., Zhang, L., Badea, B. A., White, S. K., Mais, D. E., Berger, E., Suto, C. M., Goldman, M. E., & Heyman, R. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00044a014 · Cited by 370
Ligand-independent activation of steroid hormone receptors
Weigel, N. L., & Zhang, Y. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050241 · Cited by 345
Boehm, M. F., Zhang, L., Zhi, L., McClurg, M. R., Berger, E., Wagoner, M., Mais, D. E., Suto, C. M., Davies, P. J. A., Heyman, R. A., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00016a018 · Cited by 335
Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPARγ
Uppenberg, J., Svensson, C., Jaki, M., Bertilsson, G., Jendeberg, L., & Berkenstam, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31108 · Cited by 260
Kocarek, T. A., Schuetz, E. G., Strom, S. C., Fisher, R. A., & Guzelian, P. S. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06553-5 · Cited by 230
Rat Pregnane X Receptor: Molecular Cloning, Tissue Distribution, and Xenobiotic Regulation
Zhang, H., LeCulyse, E., Liu, L., Hu, M., Matoney, L., Zhu, W., & Yan, B. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1307 · Cited by 205
Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator
Takeshita, A. (1996) · Endocrinology · doi:10.1210/en.137.8.3594 · Cited by 167
Practical Application of Computer-Aided Drug Design
Charifson, P. S. (1997) · Marcel Dekker eBooks · Cited by 163
Schuetz, E. G., Brimer, C., & Schuetz, J. D. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1113 · Cited by 155
LeCluyse, E. L., Bullock, P. L., Parkinson, A., & Hochman, J. H. (1996) · Pharmaceutical biotechnology · doi:10.1007/978-1-4899-1863-5_9 · Cited by 147
Self-citationSidhu, J. S., Farin, F. M., & Omiecinski, C. J. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1121 · Cited by 139
The nuclear receptor PPARγ-bigger than fat
Kliewer, S. A., & Willson, T. M. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80014-2 · Cited by 138
Self-citationBarwick, J. L., Quattrochi, L. C., Mills, A. S., Potenza, C., Tukey, R. H., & Guzelian, P. S. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09115-1 · Cited by 134
Isolation and culturing of hepatocytes from human livers
Li, A. P., Roque, M. A., Beck, D. J., & Kaminski, D. L. (1992) · Methods in Cell Science · doi:10.1007/bf01409104 · Cited by 111
Nichols, J. S., Parks, D. J., Consler, T. G., & Blanchard, S. G. (1998) · Analytical Biochemistry · doi:10.1006/abio.1997.2557 · Cited by 109
Hepatotoxicity of Antitubercular Treatments
Durand, F., Jébrak, G., Pessayre, D., Fournier, M., & Bernuau, J. (1996) · Drug Safety · doi:10.2165/00002018-199615060-00004 · Cited by 78
Natural ligands of nuclear receptors have conserved volumes
Bogan, A. A., Cohen, F. E., & Scanlan, T. S. (1998) · Nature Structural & Molecular Biology · doi:10.1038/1372 · Cited by 48
Berkhout, T. A., Simon, H. M., Patel, D. D., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14376 · Cited by 46
SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis
Berkhout, T. A., Simon, H. M., Jackson, B., Yates, J. W., Pearce, N., Groot, P. H. E., Bentzen, C. L., Niesor, E. J., Kerns, W., & Suckling, K. E. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00131-7 · Cited by 25
Turley, S. D., & Dietschy, J. M. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90702-9 · Cited by 18
Sm, P., Jw, M., & Hj, D. (1951) · PubMed · Cited by 13
Cited by
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Self-citationDenison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
Self-citationA G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Role of LXRs in control of lipogenesis
Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,499
Metadata
- Authors
- Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., Kliewer, S. A., & Moore, J. T.
- Venue
- Molecular Endocrinology
- Publisher
- Oxford University Press
- Published
- 2000-01-01
- Volume
- 14
- Issue
- 1
- Pages
- 27-39
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2161816485
- Cited by
- 672
- References
- 39
- FWCI
- 36.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.